Detalhe da pesquisa
1.
Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Ann Surg Oncol
; 28(8): 4655-4666, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393042
2.
Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Ann Surg Oncol
; 27(1): 179-187, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646450
3.
Defining "Complete Cytoreduction" After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis.
Ann Surg Oncol
; 27(13): 5026-5036, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32705513
4.
ASO Author Reflections: The Frailty of Patient Selection.
Ann Surg Oncol
; 28(8): 4667, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398643
5.
Inflammasome activation in neutrophils of patients with severe COVID-19.
Blood Adv
; 6(7): 2001-2013, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991159
6.
Mobile Applications: Breaking Barriers to Early Breast and Cervical Cancer Detection in Underserved Communities.
JCO Oncol Pract
; 17(3): e323-e335, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417491
7.
Overcoming Barriers in the Implementation of Programs for Breast and Cervical Cancers in Cali, Colombia: A Pilot Model.
J Glob Oncol
; 5: 1-9, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31260395